Tert-butyl (2R)-2-{[(benzyloxy)carbonyl]amino}-3-hydroxypropanoate
Structure Info
- Chemspace ID
- CSCS14929382385 (Synthesis)
- CAS
- 220095-93-2
- MFCD
- MFCD35625271
- IUPAC Name
- tert-butyl (2R)-2-{[(benzyloxy)carbonyl]amino}-3-hydroxypropanoate
- Mol formula
- C15H21NO5
- Mol weight
- 295 Da
- Catalog Number(s)
- AD267092, BBV-1240568952, EN300-51685500, HY-48934, OR1028247
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.74
- Heavy atoms count
- 21
- Rotatable bond count
- 8
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.46666666666667
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSCS14929382385
Items Overall 7 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Advanced ChemBlock Inc | 10 days | United States To: | 95 | 250 mg | 340 | |
| Advanced ChemBlock Inc | 10 days | United States To: | 95 | 1 g | 950 | |
| Advanced ChemBlock Inc | 10 days | United States To: | 95 | 5 g | 2850 | |
Description: tert-Butyl ((benzyloxy)carbonyl)-D-serinate; CAS: 220095-93-2 | ||||||
| Apollo Scientific | TBD | United Kingdom To: | 95 | 1 g | POA | |
| Apollo Scientific USA | TBD | United States To: | 95 | 1 g | POA | |
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: PD-1/PD-L1-IN-29 intermediate-1; Product Description: PD-1/PD-L1-IN-29 intermediate-1 is an intermediate of PD-1/PD-L1 inhibitors and can be used to synthesize Antibody-Drug Conjugates (ADCs).; Target: PD-1/PD-L1; CAS: 220095-93-2 | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: PD-1/PD-L1-IN-29 intermediate-1; Product Description: PD-1/PD-L1-IN-29 intermediate-1 is an intermediate of PD-1/PD-L1 inhibitors and can be used to synthesize Antibody-Drug Conjugates (ADCs).; Target: PD-1/PD-L1; CAS: 220095-93-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire